 
  


     ,  , ,          .       ,        ,       .        .





 



  



    



  ,2025

  ,  ,2025



ISBN978-5-0067-8449-9

     Ridero




 







Π


      .                  .     ,     ,  ,      .      ,  , ,        .       ,      ,      .      .

 .   .







  ,      .       ,       .              .

      ,       .        ,       ,  .            ,         .

         ,       .       ,   ,      .

            ,     .     ,    ,  , ,       .

     ,   ,  ,      .     ,    ,     .

      頖      ,   ,     .  ,  ,  ,              .




Pembrolizumab


         ,   ,  .        Pembrolizumab,      Keytruda.       ,           .

          .        ,    .  Pembrolizumab   PD-1,   ,       .

 ,  ,      ,       ,     .

       ,  ,   ,  , -    .       ,          .

 ,     ,           .           .

   Pembrolizumab   :

     ,    .

      .

          .

      .

 ,   Pembrolizumab,     .               .   ,     ,       .




Trastuzumab


       .         .          ,        Trastuzumab.  ,         .

Trastuzumab   ,        .       HER2 (human epidermal growth factor receptor 2),      .      HER2      .

  Trastuzumab :    HER2,      .      ,        HER2.

        HER2-   .          HER2/neu,       .  ,   20%        .

  ,   Trastuzumab           .             .

   Trastuzumab    .       ,    .  ,           .

 ,     , Trastuzumab   .     ,    .            .

  ,       Trastuzumab   .         ,          .

 Trastuzumab    ,         .          ,    .

 ,   Trastuzumab      ,          .




Tisagenlecleucel


 ,     (),       .      .     ˠ   Tisagenlecleucel,                 .

      ,     .     ,     .   ,   ,      .

     ,   Tisagenlecleucel,   .      :        ,     .

     :

1. Ӡ    ().

2.     ,      CAR (chimeric antigen receptor),   CD19,    B- .

3.        .

       ,   CD19,     .  ,      ,     .

    :              .     ,     .

                 . ,      ,         .

   , Tisagenlecleucel      . ,      ,     .          .

     :      ,      .  ,             .

  ,           ,     .       ,     .

 ,           .  Tisagenlecleucel          .




Olaparib


       ,           .      Olaparib, ,      ,    .

      ,   .      : ,     .        ,   Olaparib,       .

Olaparib    PARP (Poly (ADP-Ribose) Polymerase).     PARP,      .    ,     ,    .         ,   PARP     ,          .

   Olaparib   .    ,    ,   .       ,       ,    .

      .        ,   ,  ,  .  Olaparib     ,        .

    .         ,  Olaparib,  ,    .

 Olaparib   ,  ,      .  ,     ,    BRCA.        ,           .

   ࠖ   .  Olaparib  ,      ,       .

,           Olaparib,      .  ,        ,        .

        ,      ,   Olaparib.       ,      .




Atezolizumab


         .       ,  ,        .         .      Atezolizumab, ,     .

Atezolizumab       (immune checkpoint inhibitors).   ࠖ      ,    .      ,        . Atezolizumab    ,       .

      Roche  FDA (       )  2016.           (NSCLC),         ,    , ,  .

  Atezolizumab     .   ,    , ,    .        ,  ,      PD-L1 ,     .

    . ,   Atezolizumab,    ,     .       ,          .

   , Atezolizumab     .        ,     , - ,   .      ,      .

ʠ,    ,    .   ,       .            - .

  Atezolizumab .           .  ,          ,    .

    ,   Atezolizumab   ,     .        ,      .

 , Atezolizumab      ,           .




Aducanumab


       .   ,      .       Aducanumab,           .

 Aducanumab         ,    .    .    2021,        (FDA)   ,      .

      Biogen Inc.,       .           ,   ,     .

         ,   -.       ,      .  -   Aducanumab:      ,    -     .

  ,    Aducanumab          .  ,         .

   Aducanumab    .         ,      .  ,     ,    .

   . -,         . -,          . ,         .

 Aducanumab     .             ,     .   ,     Aducanumab     .

  ,           .       ,       .

 ,  Aducanumab      ,        XXI .




Exenatide


  ࠖ  ,       .              .    ,      ,   Exenatide,      .

Exenatide     GLP-1( -1),    .  GLP-1    ,         .   Exenatide    ,     ,    .

     Eli Lilly & Co., Exenatide      2005.       -      ,     .

   Exenatide     蠖     .      ,        .  , Exenatide      ,    .

 ,    Exenatide      (HbA1c) 12%,      - ,   .

  ࠖ  .      Exenatide,          .




  .


   .

   ,     (https://www.litres.ru/pages/biblio_book/?art=72383569)  .

      Visa, MasterCard, Maestro,    ,   ,     ,  PayPal, WebMoney, ., QIWI ,       .


